Your contributions to Hope Happens have a lasting impact, and great news keeps coming from the Hope Center for Neurological Disorders. This year, researchers at the Hope Center for Neurological Disorders lead by Dr. Randell Bateman developed a blood test for Alzheimer’s Disease, the first one of its kind:

A blood test to detect the brain changes of early Alzheimer’s disease has moved one step closer to reality. Researchers from Washington University School of Medicine in St. Louis report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain. The findings represent a key step toward a blood test to diagnose people on track to develop the devastating disease before symptoms arise.

Such a test will make the diagnosis simpler, more affordable and widely available!